Name: MADRIGAL PHARMACEUTICALS INC (1MDGL) Stock
Brand: MADRIGAL PHARMACEUTICALS INC
Rating: 4 (3 reviews)

Free users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

Show Percentage Diff	TTM (2025-6-30)	2024 (2024-12-31)	2023 (2023-12-31)	2022 (2022-12-31)	2021 (2021-12-31)
Revenue	515.55M	180.13M	0	0	0
Gross Premiums Earned	null	null	null	null	null
Loss Claims	null	null	null	null	null
Deferred Policy Acquisition Expense	null	null	null	null	null
Net Interest Income	null	null	null	null	null
Non Interest Income	null	null	null	null	null
Loan Loss Provision	null	null	null	null	null
Net Interest Income after Provision	null	null	null	null	null
Non Interest Expense	null	null	null	null	null
Minority Interest Expense	null	null	null	null	null
Cost Of Goods	19.18M	6.23M	null	null	null
Gross Profit	496.37M	173.90M	null	null	null
Operating Expenses	806.18M	671.77M	380.50M	293.60M	242.50M
Research and Development	192.64M	236.72M	272.35M	245.40M	205.20M
Selling, General, and Administrative Expenses	613.54M	435.06M	108.15M	48.10M	37.30M
Operating Income	-309.81M	-497.88M	-380.50M	-293.60M	-242.50M
Interest Income/Expense	27.96M	31.98M	6.87M	-1.80M	400.00K
Other Income/Expense	null	null	0	0	300.00K
Non Recurring Items	null	null	null	null	null
Income Before Taxes	-281.90M	-465.89M	-373.63M	-295.40M	-241.80M
Income Tax	null	null	null	null	null
Net Income	-281.90M	-465.89M	-373.63M	-295.40M	-241.80M
EBITDA	-308.40M	-496.78M	-379.97M	-293.13M	-242.09M

Per Share Data
EPS Diluted Total Ops	-12.8468	-21.9007	-19.9933	-17.27	-14.65
Non GAAP EPS	-12.85	-22.11	-19.94	-17.23	-14.610000000000001

Statistics
Gross Profit Margin	96.28%	96.54%	N/A	N/A	N/A
Profit Margin	-54.68%	-258.64%	N/A	N/A	N/A
Operating Profit Margin	-60.09%	-276.39%	N/A	N/A	N/A

All data in USD

MADRIGAL PHARMACEUTICALS INC (1MDGL.MI) Stock Income Statement

Charts